I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Efficacy and safety of nivolumab for patients with pre-trea..:
Girard, Nicolas
;
Ponce Aix, S
;
Cedres, S
...
uri/info:doi/10.1016/j.esmoop.2023.101576. , 2023
Link:
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac...
RT Journal T1
Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial
UL https://suche.suub.uni-bremen.de/peid=base-ftunivbruxelles:oai:dipot.ulb.ac.be:2013_362468&Exemplar=1&LAN=DE A1 Girard, Nicolas A1 Ponce Aix, S A1 Cedres, S A1 Berghmans, Thierry A1 Burgers, S A1 Toffart, Anne-Claire A1 Phalke, Swati Popat A1 Janssens, A A1 Gervais, R A1 Hochstenbag, M A1 Cardoso da Silva, M A1 Burger, I A A1 Prosch, Helmut A1 Stahel, R A1 Xenophontos, E A1 Pretzenbaher, Y A1 Neven, A A1 Peters, S YR 2023 K1 Sciences bio-médicales et agricoles K1 Humans K1 Male K1 Female K1 Middle Aged K1 Nivolumab -- adverse effects K1 Ipilimumab -- adverse effects K1 Thymoma -- drug therapy -- chemically induced K1 Thymus Neoplasms -- drug therapy -- chemically induced K1 Progression-Free Survival K1 immunotherapy K1 thymic carcinoma K1 thymoma JF uri/info:doi/10.1016/j.esmoop.2023.101576 LK http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/362468 DO http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/362468 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)